Interpace Diagnostics Group, Inc. 4
4 · Interpace Diagnostics Group, Inc. · Filed Mar 20, 2017
Insider Transaction Report
Form 4
Early James
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2017-03-16+14,475→ 14,475 totalExercise: $2.12Exp: 2027-03-16→ Common Stock (14,475 underlying)
Footnotes (1)
- [F1]The option award vests and becomes exercisable over a one-year period, commencing on March 16, 2017, in twelve equal installments, on the 15th day of each calendar month, subject to the reporting person's continued service with the issuer.